Patents by Inventor Jenifer Heydinger Galante

Jenifer Heydinger Galante has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10751314
    Abstract: Methods for enhancing joint function and for treating or preventing age-related joint discomfort in an adult human are disclosed. The methods comprise administering to the human a dietetic food, medical food, or food supplement. The food or food supplement comprises a rumenic acid-rich conjugated linoleic acid (RAR-CLA), or a pharmaceutically acceptable salt, ester, mono-, di-, or triglyceride, metabolic precursor thereof, or mixture thereof, in an amount effective to enhance joint function or to alleviate joint discomfort in the human. The RAR-CLA comprises cis-9, trans-11 linoleic acid and trans-10, cis-12 linoleic acid isomers in a weight ratio of at least 2:1. Enrichment of a dietetic food, medical food, or food supplement with RAR-CLA can help to improve joint function and/or alleviate joint discomfort. Longer-term studies should help to further elucidate the potential impact of RAR-CLA supplementation on joint function in older adults.
    Type: Grant
    Filed: June 20, 2017
    Date of Patent: August 25, 2020
    Assignee: STEPAN SPECIALTY PROFDUCTS, LLC
    Inventors: Jenifer Heydinger Galante, Hiskias Gerrit Keizer
  • Patent number: 10736868
    Abstract: Methods for treating or preventing age-related cognitive impairment in an adult human are disclosed. One method comprises administering to an adult human having, or at risk of having, impaired cognitive function a dietetic food, medical food, or food supplement. The food or food supplement comprises a rumenic acid-rich conjugated linoleic acid (RAR-CLA), or a pharmaceutically acceptable salt, ester, mono-, di-, or triglyceride, metabolic precursor thereof, or mixture thereof, in an amount effective to enhance cognitive function in the human. The RAR-CLA comprises cis-9, trans-11 linoleic acid and trans-10, cis-12 linoleic acid isomers in a weight ratio of at least 2:1. Enrichment of a dietetic food, medical food, or food supplement with RAR-CLA can help to improve cognitive function. The impact is particularly evident in aging adult males, as indicated by their improved scores in the Rey Auditory Verbal Learning Test.
    Type: Grant
    Filed: June 20, 2017
    Date of Patent: August 11, 2020
    Assignee: STEPAN SPECIALTY PRODUCTS, LLC
    Inventors: Hiskias Gerrit Keizer, Jenifer Heydinger Galante
  • Publication number: 20190231727
    Abstract: Methods for enhancing joint function and for treating or preventing age-related joint discomfort in an adult human are disclosed. The methods comprise administering to the human a dietetic food, medical food, or food supplement. The food or food supplement comprises a rumenic acid-rich conjugated linoleic acid (RAR-CLA), or a pharmaceutically acceptable salt, ester, mono-, di-, or triglyceride, metabolic precursor thereof, or mixture thereof, in an amount effective to enhance joint function or to alleviate joint discomfort in the human. The RAR-CLA comprises cis-9, trans-11 linoleic acid and trans-10, cis-12 linoleic acid isomers in a weight ratio of at least 2:1. Enrichment of a dietetic food, medical food, or food supplement with RAR-CLA can help to improve joint function and/or alleviate joint discomfort. Longer-term studies should help to further elucidate the potential impact of RAR-CLA supplementation on joint function in older adults.
    Type: Application
    Filed: June 20, 2017
    Publication date: August 1, 2019
    Inventors: Jenifer HEYDINGER GALANTE, Hiskias Gerrit KEIZER
  • Publication number: 20190142779
    Abstract: Methods for treating or preventing age-related cognitive impairment in an adult human are disclosed. One method comprises administering to an adult human having, or at risk of having, impaired cognitive function a dietetic food, medical food, or food supplement. The food or food supplement comprises a rumenic acid-rich conjugated linoleic acid (RAR-CLA), or a pharmaceutically acceptable salt, ester, mono-, di-, or triglyceride, metabolic precursor thereof, or mixture thereof, in an amount effective to enhance cognitive function in the human. The RAR-CLA comprises cis-9, trans-11 linoleic acid and trans-10, cis-12 linoleic acid isomers in a weight ratio of at least 2:1. Enrichment of a dietetic food, medical food, or food supplement with RAR-CLA can help to improve cognitive function. The impact is particularly evident in aging adult males, as indicated by their improved scores in the Rey Auditory Verbal Learning Test.
    Type: Application
    Filed: June 20, 2017
    Publication date: May 16, 2019
    Inventors: Hiskias Gerrit KEIZER, Jenifer HEYDINGER GALANTE
  • Publication number: 20170152534
    Abstract: A process for preparing a conjugated linoleic acid (CLA) material that is enriched in the cis 9, trans 11 (rumenic acid) CLA isomer. The process involves subjecting a material containing at least 75 weight % CLA moieties to an enzymatic conversion, wherein the enzyme has the ability to discriminate between the cis 9, trans 11 and trans 10, cis 12 isomers. The enzyme is advantageously a lipase derived from Candida rugosa. The resulting CLA product stream is distilled to separate the free fatty acid fraction from the glyceride fraction. The recovered free fatty acid fraction contains about 55 weight % to about 70 weight % of the cis 9, trans 11 isomer (rumenic acid), and has a weight ratio of cis 9, trans 11 isomer to trans 10, cis 12 isomer of at least 3.5:1. The material enriched in rumenic acid may be used in foods, particularly infant formulas, or in food supplements or in pharmaceutical compositions.
    Type: Application
    Filed: February 9, 2017
    Publication date: June 1, 2017
    Inventors: Vladimir Dragan, Jenifer Heydinger Galante, Jos Heimerikx
  • Patent number: 9051260
    Abstract: The present technology provides a process of reducing, removing or eliminating organohalo, glycidol, and oxirane species from carboxylic acid esters streams and crude and refined triglyceride oils to provide a carboxylic acid ester stream or triglyceride oil with reduced levels or essentially free of organohalo, glycidyl or other oxirane species. The process includes adding to the carboxylic acid ester stream or triglyceride oil an amount of a carboxylate anion and a cation counterion sufficient to react with the organohalo, glycidyl and oxirane species present.
    Type: Grant
    Filed: September 2, 2011
    Date of Patent: June 9, 2015
    Assignee: STEPAN SPECIALITY PRODUCTS, LLC
    Inventors: Joseph C. Rongione, Jenifer Heydinger Galante
  • Publication number: 20130197250
    Abstract: The present technology provides a process of reducing, removing or eliminating organohalo, glycidol, and oxirane species from carboxylic acid esters streams and crude and refined triglyceride oils to provide a carboxylic acid ester stream or triglyceride oil with reduced levels or essentially free of organohalo, glycidyl or other oxirane species. The process includes adding to the carboxylic acid ester stream or triglyceride oil an amount of a carboxylate anion and a cation counterion sufficient to react with the organohalo, glycidyl and oxirane species present.
    Type: Application
    Filed: September 2, 2011
    Publication date: August 1, 2013
    Applicant: STEPAN SPECIALTY PRODUCTS, LLC
    Inventors: Joseph C. Rongione, Jenifer Heydinger Galante
  • Patent number: 8203012
    Abstract: A process for preparing conjugated linoleic acid (CLA) or derivatives thereof from ricinoleic acid, lower alkyl esters of ricinoleic acid, or salts thereof. The CLA is formed by reacting a carboxylic acid, or anhydride, anhydride equivalent, or ester thereof with the ricinoleic acid or derivative to form an intermediate having a carboxylic ester at the 12-hydroxy position of the ricinoleic acid or derivative, and reacting the intermediate with a base to form a cis-9, trans-11 conjugated linoleic acid.
    Type: Grant
    Filed: December 5, 2006
    Date of Patent: June 19, 2012
    Assignee: Stepan Company
    Inventors: Joseph C. Rongione, Jenifer Heydinger Galante, Randal J. Bernhardt
  • Patent number: 7807718
    Abstract: Provided are alternative sources of ketone bodies for reducing or eliminating symptoms of Parkinson's disease, amyotrophic lateral sclerosis (ALS, also called Lou Gehrig's disease), Alzheimer's disease, Huntington's disease, epilepsy and other diseases or disorders characterized by impaired glucose metabolism. The alternative sources of ketone bodies include mono-, di- and triglyceride esters of acetoacetate and mixtures thereof, and/or mono-, di- and triglyceride esters of 3-hydroxybutyrate and mixtures thereof. These glyceride esters can be administered orally as a dietary supplement or in a nutritional composition.
    Type: Grant
    Filed: June 29, 2007
    Date of Patent: October 5, 2010
    Inventors: Sami A. Hashim, Joanna Jusis, Jenifer Heydinger Galante, Joseph C. Rongione
  • Patent number: 7759096
    Abstract: A process for enzymatic production of glyceride compositions, specifically industrially practicable production of triglycerides, including conjugated linoleic and linolenic acid triglycerides, and the compositions produced by such process. An enzymatic reaction zone is first utilized, in which a mixture of glycerol and fatty acids or fatty acid derivatives is reacted in the presence of an enzymatic catalyst to form 1,3 diglycerides. The mixture is then circulated through a second thermal rearrangement zone, maintained at a higher temperature, to promote rearrangement of the 1,3 diglycerides to 1,2 diglycerides. Triglycerides are produced by re-circulating the mixture through the enzymatic production zone.
    Type: Grant
    Filed: January 29, 2004
    Date of Patent: July 20, 2010
    Assignee: Stepan Company
    Inventors: Jenifer Heydinger Galante, Steven L. Clauss, Randal J. Bernhardt, Alfred K. Schultz
  • Publication number: 20100036142
    Abstract: A process for preparing conjugated linoleic acid (CLA) or derivatives thereof from ricinoleic acid, lower alkyl esters of ricinoleic acid, or salts thereof. The CLA is formed by reacting a carboxylic acid, or anhydride, anhydride equivalent, or ester thereof with the ricinoleic acid or derivative to form an intermediate having a carboxylic ester at the 12-hydroxy position of the ricinoleic acid or derivative, and reacting the intermediate with a base to form a cis-9, trans-11 conjugated linoleic acid.
    Type: Application
    Filed: December 5, 2006
    Publication date: February 11, 2010
    Inventors: Joseph C. Rongione, Jenifer Heydinger Galante, Randal J. Bernhardt
  • Publication number: 20090197952
    Abstract: Provided are alternative sources of ketone bodies for reducing or eliminating symptoms of Parkinson's disease, amyotrophic lateral sclerosis (ALS, also called Lou Gehrig's disease), Alzheimer's disease, Huntington's disease, epilepsy and other diseases or disorders characterized by impaired glucose metabolism. The alternative sources of ketone bodies include mono-, di- and triglyceride esters of acetoacetate and mixtures thereof, and/or mono-, di- and triglyceride esters of 3-hydroxybutyrate and mixtures thereof. These glyceride esters can be administered orally as a dietary supplement or in a nutritional composition.
    Type: Application
    Filed: June 29, 2007
    Publication date: August 6, 2009
    Inventors: Sami A. Hashim, Joanna Jusis, Jenifer Heydinger Galante, Joseph C. Rongione
  • Publication number: 20090131701
    Abstract: A process for enzymatic production of glyceride compositions, specifically industrially practicable production of triglycerides, including conjugated linoleic and linolenic acid triglycerides, and the compositions produced by such process. An enzymatic reaction zone is first utilized, in which a mixture of glycerol and fatty acids or fatty acid derivatives is reacted in the presence of an enzymatic catalyst to form 1,3 diglycerides. The mixture is then circulated through a second thermal rearrangement zone, maintained at a higher temperature, to promote rearrangement of the 1,3 diglycerides to 1,2 diglycerides. Triglycerides are produced by re-circulating the mixture through the enzymatic production zone.
    Type: Application
    Filed: January 29, 2004
    Publication date: May 21, 2009
    Applicant: STEPAN COMPANY
    Inventors: Jenifer Heydinger Galante, Steven L. Clauss, Randal J. Bernhardt, Alfred K. Schultz
  • Patent number: 7087771
    Abstract: A method for making alkyl esters (e.g., methyl ester), such as biodiesel, from an oil source is described. The method involves converting the free fatty acids of the oil source into a mixture of mono-, di-, and tri-glycerides and subsequently transesterifying the newly formed glycerides as well as the originally present glycerides into fatty acid alkyl esters.
    Type: Grant
    Filed: September 29, 2004
    Date of Patent: August 8, 2006
    Assignee: Biosource America, Inc.
    Inventors: Franz J. Luxem, Jenifer Heydinger Galante, William M. Troy, Randal J. Bernhardt
  • Patent number: 6897327
    Abstract: A process to manufacture conjugated linoleic acid (CLA)-containing materials such as conjugated linoleic salts and acids that are enriched in desirable cis-9, trans-11- and trans-10, cis-12-CLA isomers and are low in certain undesirable isomers. The process generally entails isomerization of an alkyl ester of a linoleic acid-containing material at a temperature typically between about 90 to 140° C. to effectuate conjugation of the double bonds, followed by saponification of the resultant CLA-containing fatty acid ester to produce a CLA-containing fatty acid salt, optionally followed by neutralization of the CLA-containing fatty acid salt with an acid source to produce a CLA-containing fatty acid.
    Type: Grant
    Filed: May 8, 2003
    Date of Patent: May 24, 2005
    Assignee: Stepan Company
    Inventors: Joseph C. Rongione, Jenifer Heydinger Galante, Steven L. Clauss, Randal J. Bernhardt, Phouvieng Xayariboun
  • Patent number: 6822105
    Abstract: A method for making alkylesters, or methylester specifically, such as biodiesel, from an oil source is described. The method involves converting the free fatty acids of the oil source into a mixture of mono-, di-, and tri-glycerides and subsequently transesterifying the newly formed glycerides as well as the originally present glycerides into fatty acid alkyl esters.
    Type: Grant
    Filed: August 12, 2003
    Date of Patent: November 23, 2004
    Assignee: Stepan Company
    Inventors: Franz J. Luxem, Jenifer Heydinger Galante, William M. Troy, Randall R. Bernhardt
  • Publication number: 20040225141
    Abstract: A process to manufacture conjugated linoleic acid (CLA)-containing materials such as conjugated linoleic salts and acids that are enriched in desirable cis-9, trans-11- and trans-10, cis-12-CLA isomers and are low in certain undesirable isomers. The process generally entails isomerization of an alkyl ester of a linoleic acid-containing material at a temperature typically between about 90 to 140° C. to effectuate conjugation of the double bonds, followed by saponification of the resultant CLA-containing fatty acid ester to produce a CLA-containing fatty acid salt, optionally followed by neutralization of the CLA-containing fatty acid salt with an acid source to produce a CLA-containing fatty acid.
    Type: Application
    Filed: May 8, 2003
    Publication date: November 11, 2004
    Inventors: Joseph C. Rongione, Jenifer Heydinger Galante, Steven L. Clauss, Randal J. Bernhardt, Phouvieng Xayariboun
  • Publication number: 20040225143
    Abstract: A process to manufacture conjugated linoleic acid (CLA)-containing materials such as conjugated linoleic salts and acids that are enriched in desirable cis-9, trans-11- and trans-10, cis-12-CLA isomers and are low in certain undesirable isomers. The process generally entails isomerization of an alkyl ester of a linoleic acid-containing material at a temperature typically between about 90 to 140° C. to effectuate conjugation of the double bonds, followed by saponification of the resultant CLA-containing fatty acid ester to produce a CLA-containing fatty acid salt, followed by neutralization of the CLA-containing fatty acid salt with an acid source to produce a CLA-containing fatty acid.
    Type: Application
    Filed: June 4, 2004
    Publication date: November 11, 2004
    Inventors: Joseph C. Rongione, Jenifer Heydinger Galante, Steven L. Clauss, Randal J. Bernhardt, Phouvieng Xayariboun
  • Patent number: RE48861
    Abstract: The present technology provides a process of reducing, removing or eliminating organohalo, glycidol, and oxirane species from carboxylic acid esters streams and crude and refined triglyceride oils to provide a carboxylic acid ester stream or triglyceride oil with reduced levels or essentially free of organohalo, glycidyl or other oxirane species. The process includes adding to the carboxylic acid ester stream or triglyceride oil an amount of a carboxylate anion and a cation counterion sufficient to react with the organohalo, glycidyl and oxirane species present.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: December 28, 2021
    Assignee: STEPAN SPECIALTY PRODUCTS, LLC
    Inventors: Joseph C. Rongione, Jenifer Heydinger-Galante